Individual photo

A clear, well-defined strategy, timing and consistency of communication are pivotal to successful market access

Our knowledge of key market access barriers across diverse disease areas and geographies places us in a strong position to support a wide variety of market access projects for a variety of stakeholders at the global and local levels.

We pride ourselves on the written quality, technical accuracy, compelling narratives and creative presentation of our market access materials, which range from value dossiers to customer-facing economic models.

Our Market Access team has a deep understanding of decision-maker priorities and requirements at each stage of the access journey, based on our extensive experience across:

Our multidisciplinary market access experience spans:

Planning & Strategy

  • Market access landscaping and needs assessments
  • Early scientific advice support
  • Key value message development and validation
  • Strategic HTA appraisal review to inform reimbursement and submission strategies
  • Strategic planning, gap analyses and evidence generation planning

Evidence Generation

  • Literature reviews
  • Clinical and market access expert validation, including via workshops, roundtables and advisory boards

Internal Resource & Training

  • Global, regional, and local dossiers
  • Internal market access training materials and activities, including value material rollout workshops
  • Value story slide sets
  • Objection handling documents

External Value Materials

  • Original research and literature review publications
  • Evidence-based product brochures
  • Advanced budgetary notification (ABN) materials
Opinion Piece Illustration

Value Dossier Development

Compelling, evidence-driven and fit-for-purpose value dossiers are more important than ever in today’s increasingly challenging reimbursement environment, as a high-quality value dossier can play a key role in  preparations for the launch of a new product.

Our market access team will be sharing their reflections on best practices for efficient development of robust value dossiers across the next month or so, including our experience of how this varies across sectors:

  • Our 5 key tips for a developing a winning value dossier
  • Our experiences of generative AI in value dossier writing
  • Our approach to developing compelling value dossiers in the rare diseases space
  • Our top tips for developing impactful value dossiers for medical devices
  • Our suggestions on incorporating patient centricity during value dossier development

For more information on our Market Access services or to request a quote, please contact Catherine Bunting

Get In Touch